Bristol Myers Squibb agrees to pay $75 million to settle allegations of underpaying Medicaid rebates

first_img What is it? What’s included? GET STARTED [email protected] Courtesy Bristol Myers Squibb Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+. First 30 days free. GET STARTED About the Author Reprints After years of litigation, Bristol Myers Squibb (BMY) agreed to pay $75 million, plus interest, to resolve allegations of knowingly underpaying rebates that were owed to state Medicaid programs.The settlement, which the company had signaled a year ago was in the works, stems from a whistleblower lawsuit filed in 2013 by the former head of a health care industry trade group who had filed similar suits against several drug makers. @Pharmalot Ed Silvermancenter_img Log In | Learn More Pharmalot Bristol Myers Squibb agrees to pay $75 million to settle allegations of underpaying Medicaid rebates By Ed Silverman April 2, 2021 Reprints STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. Tags drug pricinglegalSTAT+last_img read more